← Back to Search

Metformin therapy for Prediabetes

N/A
Waitlist Available
Led By Andrea Cherrington, MD, MPH
Research Sponsored by University of Alabama at Birmingham
Eligibility Criteria Checklist
Specific guidelines that determine who can or cannot participate in a clinical trial
Must have
Be older than 18 years old
Timeline
Screening 3 weeks
Treatment Varies
Follow Up 12 months
Awards & highlights

Study Summary

This trial is designed to test a new way to prevent diabetes that could help people in rural counties of Alabama and in the Mississippi delta who are especially vulnerable to the disease.

Eligible Conditions
  • Prediabetes

Timeline

Screening ~ 3 weeks
Treatment ~ Varies
Follow Up ~12 months
This trial's timeline: 3 weeks for screening, Varies for treatment, and 12 months for reporting.

Treatment Details

Study Objectives

Outcome measures can provide a clearer picture of what you can expect from a treatment.
Primary outcome measures
Change in Body Weight
Change in Glycosylated Hemoglobin (HbA1c)

Trial Design

2Treatment groups
Experimental Treatment
Active Control
Group I: Receive lifestyle modification with metformin therapyExperimental Treatment2 Interventions
Participants in this arm will receive a lifestyle modification intervention program facilitated by Peer Coach (PC) services plus metformin recommendation
Group II: Receive lifestyle modification alone (DPP)Active Control1 Intervention
Participants in this arm will receive a lifestyle modification intervention program facilitated by Peer Coach (PC) services
Treatment
First Studied
Drug Approval Stage
How many patients have taken this drug
Metformin therapy
2020
N/A
~40
Receive lifestyle modification alone
2020
N/A
~40

Find a Location

Who is running the clinical trial?

National Institute of Diabetes and Digestive and Kidney Diseases (NIDDK)NIH
2,357 Previous Clinical Trials
4,315,150 Total Patients Enrolled
University of Alabama at BirminghamLead Sponsor
1,583 Previous Clinical Trials
2,280,008 Total Patients Enrolled
Andrea Cherrington, MD, MPHPrincipal Investigator - University of Alabama at Birmingham
University of Alabama at Birmingham

Media Library

Lifestyle Modification Clinical Trial Eligibility Overview. Trial Name: NCT04343872 — N/A
Prediabetes Research Study Groups: Receive lifestyle modification alone (DPP), Receive lifestyle modification with metformin therapy
Prediabetes Clinical Trial 2023: Lifestyle Modification Highlights & Side Effects. Trial Name: NCT04343872 — N/A
Lifestyle Modification 2023 Treatment Timeline for Medical Study. Trial Name: NCT04343872 — N/A

Frequently Asked Questions

These questions and answers are submitted by anonymous patients, and have not been verified by our internal team.

Are people being recruited to take part in the research currently?

"According to clinicaltrials.gov's records, this trial is not actively recruiting patients anymore since its most recent update on October 6th 2022. Although the study has closed off recruitment, there are still 1290 other trials that require participants at this time."

Answered by AI

What criteria must a person meet in order to be eligible for this medical experiment?

"This clinical trial seeks to recruit 100 participants who are aged between 19 and 59, have a BMI of at least 35, receive their primary care from one of the collaborating medical centres and have an HbA1c reading ranging between 6.0% - 6.4%. Moreover, they must commit to attending group classes, working with peer advisors both in-person and over the phone as well as self-weighing daily using telemonitoring bodyweight technology, while having access to either telephone or cellular phone services. Additionally, it is imperative that these patients have had eGFR readings above 60 within six months prior to enrolling"

Answered by AI

Is the age restriction for this trial limited to those 45 years of age or older?

"This specific clinical trial is only open to adults between the ages of 19-59. For those below the age of 18 and above 65, there are 188 and 972 respective trials available for their consideration."

Answered by AI

Who else is applying?

What state do they live in?
Alabama
What site did they apply to?
UAB
What portion of applicants met pre-screening criteria?
Met criteria
How many prior treatments have patients received?
0
2

Why did patients apply to this trial?

What questions have other patients asked about this trial?

How long are the visits?
PatientReceived 1 prior treatment
Recent research and studies
clinicaltrials.govStudy
Preventing Diabetes in the Deep South: Extending Partnerships and Adapting Interventions to Reach Rural Communities at High Risk.
Andrea Cherrington, MD 2020. "Preventing Diabetes in the Deep South: Extending Partnerships and Adapting Interventions to Reach Rural Communities at High Risk.". ClinicalTrials.gov. https://clinicaltrials.gov/ct2/show/NCT04343872.
~8 spots leftby Apr 2025
Unbiased ResultsWe believe in providing patients with all the options.
Your Data Stays Your DataWe only share your information with the clinical trials you're trying to access.
Verified Trials OnlyAll of our trials are run by licensed doctors, researchers, and healthcare companies.
Back to top